logo
Plus   Neg
Share
Email

Inovio Pharma's Ebola Vaccine Shows T Cell, Antibody Responses In Phase 1 Study

Inovio Pharmaceuticals, Inc. (INO) announced its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses, according to Phase 1 data. The company said the study demonstrated that intradermal (skin) administration with Inovio's CELLECTRA delivery device resulted in 100% of evaluable subjects generating antigen-specific antibody responses that persisted for more than one year in most subjects and generated T cell responses equivalent to or better than the group that received intramuscular delivery.

Joseph Kim, Inovio's President and CEO, said, "With strong preclinical and human data, Inovio is executing on our overall development strategy in advancing INO-4201 as a viable stockpile vaccine. Because Inovio's Ebola vaccine can be used to protect against Ebola infection and can be boosted multiple times without any anti-vector response, it could be employed to boost viral vector vaccines that cannot be effectively re-administered. We now look to secure partner funding to further advance our Ebola vaccine as a stand-alone vaccine as well as a boost for those previously immunized with viral vector vaccines."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Consumer Electronics Show have announced that it will allow sex toys to be exhibited on the floor as well as win awards next year. The organizers said CES 2020 will include tech-based sexual products on a one-year trial basis as part of the Health & Wellness product category or in the Health &... eBay Inc. (EBAY) Wednesday reported a second-quarter profit that trumped Wall Street analysts' estimates, as did revenues. Moving ahead, the company lowered its full-year revenue outlook, but lifted its earnings estimates, sending shares up nearly 5% in extended trading session. eBay's second-quarter... Shares of Netflix Inc. (NFLX) tanked 12% in extended trading session Wednesday after the online-video streaming giant reported a weak global subscriber additions, with U.S. subscribers dropping for the first-time ever. Netflix added 2.70 million subscribers globally in the quarter, far below its forecast...
Follow RTT